Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C26H35NO4 |
Molecular Weight | 425.5604 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[C@]12CC[C@@]3(C[C@@H]1C(C)(C)O)[C@H]4CC5=CC=C(O)C6=C5[C@@]3(CCN4CC7CC7)[C@H]2O6
InChI
InChIKey=OIJXLIIMXHRJJH-KNLIIKEYSA-N
InChI=1S/C26H35NO4/c1-23(2,29)18-13-24-8-9-26(18,30-3)22-25(24)10-11-27(14-15-4-5-15)19(24)12-16-6-7-17(28)21(31-22)20(16)25/h6-7,15,18-19,22,28-29H,4-5,8-14H2,1-3H3/t18-,19-,22-,24-,25+,26-/m1/s1
Molecular Formula | C26H35NO4 |
Molecular Weight | 425.5604 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:01:15 UTC 2023
by
admin
on
Sat Dec 16 17:01:15 UTC 2023
|
Record UNII |
1F0L5N25ZZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QV03AB92
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C166495
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
PRIMARY | |||
|
D004174
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
PRIMARY | |||
|
443408
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
PRIMARY | |||
|
DB01548
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
PRIMARY | |||
|
14357-78-9
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
PRIMARY | |||
|
m4650
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL281786
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
PRIMARY | |||
|
DTXSID00903941
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
PRIMARY | |||
|
238-325-7
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
PRIMARY | |||
|
1F0L5N25ZZ
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
PRIMARY | |||
|
100000082351
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
PRIMARY | |||
|
Diprenorphine
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
PRIMARY | |||
|
2639
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
PRIMARY | |||
|
SUB07220MIG
Created by
admin on Sat Dec 16 17:01:16 UTC 2023 , Edited by admin on Sat Dec 16 17:01:16 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
In contrast to naloxone, diprenorphine (0.03 mgkg−1i.p.)reversed equipotent doses of morphine and fentanyl to the same degree. Assay done on SH-SY5Y cells displacing [3H]DIPRENORPHINE.
Ki
|
||
|
TARGET -> INHIBITOR |
Ki
|
||
|
LABELED -> NON-LABELED |
|
||
|
TARGET -> INHIBITOR |
Assumed Kd similar to all opioid receptors
Kd
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
Assumed Kd similar to all opioid receptors
Kd
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|